MetrionAIResearch

Home Watchlist Market News High Impact News Market Movers Screener Portfolio Calculators Heatmap Compare Calendars Crypto Forex Macro Maps

Research Tools

Financial Analysis Analyst Estimates Insider Trading Market Guide Trading Ideas Charts

Financial Analysis

Highlights Income Statement Balance Sheet Cash Flow Multiples Profitability

Loading stock research

Loading market dashboard

My Watchlist

Create an account to keep a persistent watchlist.

Home High Impact News Market Movers

Loading stock research

Argent BioPharma Limited

RGT.L

HealthcareLSE

£6.00

-£0.50 (-7.69%)

Overview Financials Analysis Valuation Thesis Ownership Compare AI Report News

RGT.L

1Y-0.5 (-7.69%)

Candles, volume, SMA 20, and SMA 50

O 5.79H 7.85L 5.79C 6Date Dec 30

RGT.L

SMA 20 SMA 50 Vol 24.73KEEarnings dates

Open in Chartsfor further analysis

Business Description

Open for the full company profile when you need deeper context.

ShowHide

No company description is available yet.

Key Metrics

Quick size, liquidity, and volatility measures for the stock.

Market Cap?£4.18M

Volume?1.04K

Avg Volume?15.14K

52w Range£0.22 - £29.60

Beta?1.08

Price Performance

0.0%

£6.00 to £6.00

YTD

0.0%

£6.00 to £6.00

0.0%

£6.00 to £6.00

N/A

history unavailable

N/A

history unavailable

10Y

N/A

history unavailable

Company Details

CEO, industry, employees, IPO date, currency, and website.

ShowHide

CEORoby Reuven Zomer

IndustryDrug Manufacturers - Specialty & Generic

Employees0

IPO Date

CurrencyGBP

Related stocks

Check out other names from the same Drug Manufacturers - Specialty & Generic industry as RGT.L.

Cambridge Nutritional Sciences plc

Hellenic Dynamics Plc

Oncimmune Holdings plc